MOTS-C Injection: Technique Comparison
Subcutaneous (subq) 29G–31G 4–6mm into fat layer Abdomen, anterior thigh, dorsal upper arm Moderate. Peaks 30–90 min Standard route for MOTS-C; consistent bioavailability, minimal discomfort, easy self-administration Intramuscular (IM) 23G–25G 1–1.5 inches int
This comparison does not assign a generated winner or score.
- Subcutaneous (subq)
- 29G–31G
- 4–6mm into fat layer
- Abdomen, anterior thigh, dorsal upper arm
- Moderate. Peaks 30–90 min
- Standard route for MOTS-C; consistent bioavailability, minimal discomfort, easy self-administration
- Intramuscular (IM)
- 23G–25G
- 1–1.5 inches into muscle
- Vastus lateralis, gluteus, deltoid
- Faster. Peaks 15–45 min
- Not typically used for MOTS-C; no documented bioavailability advantage and higher injection site pain
- Intravenous (IV)
- 20G–22G
- Direct venous access
- Antecubital fossa, hand veins
- Immediate. Systemic within seconds
- Requires clinical setting; bypasses first-pass metabolism but offers no therapeutic benefit for MOTS-C's mechanism